DebraLPowellMD

Chair, Department of Medicine at Tower Health Reading Hospital Division Chief of Infectious Diseases

Dr. Powell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
301 S 7th Ave
Suite 120
West Reading, PA 19611
Phone+1 484-628-4630

Fax+1 610-374-8324

Dr. Debra Powell is an infectious disease specialist in West Reading, PA and is affiliated with Reading Hospital. She received her medical degree from Pennsylvania State University College of Medicine and has been in practice 14 years. She is experienced in HIV/AIDS, tick-borne diseases, infection control, antibiotic stewardship, and bacterial infections. She has several publications.

Penn State Milton S Hershey Medical CenterFellowship, Infectious Disease, 2006 - 2008
Tower HealthResidency, Internal Medicine, 2003 - 2006
Pennsylvania State University College of MedicineClass of 2003

PubMed

23 citations
Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.
John N Aucott, Ting Yang, Isaac Yoon, Debra Powell, Steven A Geller
International Journal of Infectious Diseases. 2022-03-01
8 citations
The presenting characteristics of erythema migrans vary by age, sex, duration, and body location.
Alison W. Rebman, Ting Yang, Erica A. Mihm, Cheryl B. Novak, Isaac Yoon
Infection. 2021-03-07
Fulminant Soft Tissue Infection with Intestinal Ischemia Associated with Staphylococcus lugdunensis.
Jaclyn Malat, Laura Rivera, Thomas A. Geng, Debra Powell, Vincente Cortes
The American Surgeon. 2018-09-01

Journal Articles

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Tho...
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison..., Lancet PMID: 36442484, 1/7/2023
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study
Al Ozonoff, Debra Powell, et al, EBioMedicine, 8/2022
Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study
John N Aucott, Ting Yang, Isaac Yoon, Debra Powell, Steven A Geller, Alison W Rebman, Int J Infect Dis, 3/2022
The presenting characteristics of erythema migrans vary by age, sex, duration, and body location
Alison W Rebman, Ting Yang, Erica A Mihm, Cheryl B Novak, Isaac Yoon, Debra Powell, Steven A Geller, John N Aucott, Infection, 8/2021
In community-acquired bacterial pneumonia, lefamulin was noninferior to moxifloxacin at 96 h after the first dose
Debra Powell, Anthony Donato, Ann Intern Med, 2/18/2020
Join now to see all

Tower Health Recognizes Two Years of COVID-19 in the CommunityMarch 16th, 2022
COVID Increased PA Hospitalization Deaths from Serious Medical Conditions by 25%, Doubled CostsDecember 20th, 2021
Third Shot’s a Charm: Who Is Eligible for a COVID Vaccine Booster and Why They Should Get ItOctober 12th, 2021
Join now to see all